Percent of cancer in the biopsy set predicts pathological findings after prostatectomy

Journal of Urology

Volumn 167, Issue 5, 2002, Pages 2032-2036

  Grossklaus, David J ^a,b   Coffey, Christopher S ^a,b   Shappell, Scott B ^a,b   Jack, Gregory S ^a,b   Chang, Sam S ^a,b   Cookson, Michael S ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Biopsy, needle; Neoplasm staging; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; STATISTICAL MODEL; TUMOR VOLUME;

EID: 0036227687     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65077-X     Document Type: Article

References (26)

1. Prostate-specific antigen: Current status
2. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
3. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
4. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage TlC) prostate cancer
5. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy
6. Ability of sextant biopsies to predict radical prostatectomy stage
7. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy
8. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?
9. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: Application in selecting patients for nerve sparing surgery
10. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies
11. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy
12. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
13. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
14. Anatomic considerations in carcinoma of the prostate
15. Prediction of prognosis for prostate carcinoma by combined histological grading and clinical staging
16. Prediction of capsular perforation and seminal vesical invasion in prostate cancer
17. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease
18. Morphometric and clinical studies on 68 consecutive radical prostatectomies
19. Tumor volume and prostate specific antigen: Implications for early detection and defining a window of curability
20. Prostate specific antigen: A decade of discovery - What we have learned and where we are going
21. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues
22. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer
23. Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer
24. Sextant prostate biopsies: A histopathologic correlation with radical prostatectomy specimens
25. Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: A preliminary report
26. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis